Vanguard Group Inc Clear Point Neuro, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,283,978 shares of CLPT stock, worth $15.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,283,978
Previous 1,248,393
2.85%
Holding current value
$15.2 Million
Previous $19.2 Million
20.49%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CLPT
# of Institutions
105Shares Held
8.14MCall Options Held
243KPut Options Held
30.2K-
Israel Englander Millennium Management LLC | New York, Ny741KShares$8.75 Million0.01% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA482KShares$5.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$4.33 Million0.0% of portfolio
-
Brown Advisory Inc331KShares$3.91 Million0.01% of portfolio
-
Essex Investment Management CO LLC Boston, MA327KShares$3.87 Million0.88% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $289M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...